about
A summary of the new GINA strategy: a roadmap to asthma controlThe GINA asthma strategy report: what's new for primary care?Inter-professional education unveiling significant association between asthma knowledge and inhaler techniqueDouble blind randomised controlled trial of two different breathing techniques in the management of asthma.Effect of novel inhaler technique reminder labels on the retention of inhaler technique skills in asthma: a single-blind randomized controlled trial.Diurnal variability--time to change asthma guidelines?Impact of graphic format on perception of change in biological data: implications for health monitoring in conditions such as asthma.Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia.The reduction of rhinitis symptoms by nasal filters during natural exposure to ragweed and grass pollen.Bronchodilator activity of prazosin in patients with allergic rhinitis and asthmaThe effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial.Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps.Barriers and facilitators to patient recruitment to a cluster randomized controlled trial in primary care: lessons for future trialsThe need for standardisation of peak flow charts.A pragmatic cluster randomized controlled trial of early intervention for chronic obstructive pulmonary disease by practice nurse-general practitioner teams: Study ProtocolPeak flow monitoring in clinical practice and clinical asthma trials.Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment.Pharmacological strategies for self-management of asthma exacerbations.A new perspective on concepts of asthma severity and control.An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials.Asthma: time to confront some inconvenient truths.Year-in-review 2009: Asthma, COPD and airway biology.Does the current stepwise approach to asthma pharmacotherapy encourage over-treatment?Year-in-review 2010: asthma, COPD, cystic fibrosis and airway biology.Treating according to asthma control: does it work in real life?Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial.Checklists for powder inhaler technique: a review and recommendations.Combination corticosteroid/β-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma?Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis.Self-management support and other alternatives to reduce the burden of asthma and chronic obstructive pulmonary disease.The reliability and utility of spirometry performed on people with asthma in community pharmacies.The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?Is higher population-level use of ICS/LABA combination associated with better asthma outcomes? Cross-sectional surveys of nationally representative populations in New Zealand and Australia."This illness diminishes me. What it does is like theft": A qualitative meta-synthesis of people's experiences of living with asthma.Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap.Severe asthma: Current management, targeted therapies and future directions-A roundtable report.Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma.Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations.Effect of smoking status on the efficacy of the SMART regimen in high risk asthma.
P50
Q26799984-D1E18F93-3083-47E0-AF4A-5F33023B2D86Q26801700-FB147D72-E062-4C78-95DB-34F97A48819BQ28390058-690D984E-238B-49D2-A3B4-464679D5F8A2Q30480785-38C30674-680D-4FEF-90DF-1920CC150D27Q30851184-FE4B9906-A16B-4C33-853A-09253A5D297CQ33796588-670BBEFE-765A-4D0F-9AE9-9534990A4FA7Q34136574-2627CCD3-301D-4E6A-9C97-A2A0DCD7A19BQ34308022-B38549F1-CF3F-4873-A7D0-B0D05C14A867Q34396953-E18CC1A8-C639-48F8-8194-06077A58AA7DQ34450154-81E0697C-D7B9-4766-9E26-521EB13D097AQ34480446-4CB2F4C2-7E5A-420F-ACDE-67192AE6D133Q34855300-DE9F2C88-8A7D-4C76-B75A-02B3F59821B1Q35204262-996A4DF0-4695-47C5-BF9C-58163290D406Q35537458-6B3239D1-8827-42C0-9940-A4E3B54ED7E6Q36278452-192F773C-E78F-4FBB-B801-D15896D661C7Q36343346-1FE4790C-AB4D-466B-BA83-D15EB373C1B2Q36352557-E83920A5-42C8-446B-99AB-B4FB6E865745Q36525617-4D37BCAE-7249-49EE-89B2-CC32B9AE5FE1Q37256164-033E3BFC-994C-4039-8BD1-56812227A078Q37522916-AAEB8B73-E73A-4BD5-A14B-DDAB7A5D6EF4Q37576228-3C78B78E-765E-4CB4-A25B-318EAB0B7580Q37701957-0D55A419-18A0-457A-A561-6B2191B5BEEDQ37701963-A4E70F3E-4BC4-42CC-88D7-8AE77608D1DBQ37729357-E1460856-FE28-4392-BC7C-7BF938584F4BQ37845433-2357C134-EA83-43A3-B176-018D97BEA731Q38038711-628D30A2-F000-4081-9758-61544A2ED3D7Q38070007-24B665FD-2646-42BD-BA89-5456055DE706Q38152941-A92D8FAA-BB29-4419-9BBE-4E6CF1C26E39Q38173909-FF2CF1F1-D8AD-43A5-A889-FAEBE540C188Q38219526-F111BABB-6A20-4192-8360-39222F4F346EQ38291834-B90D643C-2EFE-49F0-A867-38B0157EF3CDQ38308864-EFB61995-A456-48C4-9836-022C190BA1DDQ38563023-AD627E81-EED4-494A-9A06-71A2D7C8249AQ38632713-1DB75195-F93E-4AD8-B8FB-3DD28A4A1B67Q38646534-957BB3FD-C295-4A46-99CC-A0E719588DD1Q38782541-25E150ED-C8C0-4CDD-A832-027C17F4FF4DQ38788721-C799080C-82FC-47B1-8530-4C9F4B7A0104Q39091842-2B43DD5C-582C-4D92-99FC-EBB17CD88F76Q39122851-DD574F1D-BD7A-4AD0-9694-D1FF9C951869Q39176351-86C23664-224C-4AB2-87B0-B87C28883B3D
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Helen K Reddel
@ast
Helen K Reddel
@en
Helen K Reddel
@es
Helen K Reddel
@nl
Helen K Reddel
@sl
type
label
Helen K Reddel
@ast
Helen K Reddel
@en
Helen K Reddel
@es
Helen K Reddel
@nl
Helen K Reddel
@sl
prefLabel
Helen K Reddel
@ast
Helen K Reddel
@en
Helen K Reddel
@es
Helen K Reddel
@nl
Helen K Reddel
@sl
P106
P21
P31
P496
0000-0002-6695-6350